| Brandon Earle Pruett, MD | |
|
3601 The Vanderbilt Clinic, Nashville, TN 37232-0028 | |
| (615) 322-3000 | |
| Not Available |
| Full Name | Brandon Earle Pruett |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 8 Years |
| Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023464302 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vanderbilt University Medical Center | Nashville, TN | Hospital |
| Vanderbilt Wilson County Hospital | Lebanon, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
A new study suggests that when prescribed by physicians in routine practice and used appropriately by patients, treatment for obstructive sleep apnea (OSA) could reduce blood pressure in men with hypertension.
Tamro Group net sales in August-October 2010 amounted to EUR 1,475 million, an increase of 7.6%. The increase in sales is driven by organic growth in several markets, accounting for 4.2%, but also by strengthened foreign currencies, for the remaining 3.4%.
For years, it was believed that obese women were at lower risk for developing osteoporosis, and that excess body fat actually protected against bone loss. However, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) found that having too much internal abdominal fat may, in fact, have a damaging effect on bone health.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment in elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.
› Verified 1 days ago
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
A new study suggests that when prescribed by physicians in routine practice and used appropriately by patients, treatment for obstructive sleep apnea (OSA) could reduce blood pressure in men with hypertension.
Tamro Group net sales in August-October 2010 amounted to EUR 1,475 million, an increase of 7.6%. The increase in sales is driven by organic growth in several markets, accounting for 4.2%, but also by strengthened foreign currencies, for the remaining 3.4%.
For years, it was believed that obese women were at lower risk for developing osteoporosis, and that excess body fat actually protected against bone loss. However, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) found that having too much internal abdominal fat may, in fact, have a damaging effect on bone health.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment in elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandon Earle Pruett, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: () - | Brandon Earle Pruett, MD 3601 The Vanderbilt Clinic, Nashville, TN 37232-0028 Ph: (615) 322-3000 |
News Archive
A new study suggests that when prescribed by physicians in routine practice and used appropriately by patients, treatment for obstructive sleep apnea (OSA) could reduce blood pressure in men with hypertension.
Tamro Group net sales in August-October 2010 amounted to EUR 1,475 million, an increase of 7.6%. The increase in sales is driven by organic growth in several markets, accounting for 4.2%, but also by strengthened foreign currencies, for the remaining 3.4%.
For years, it was believed that obese women were at lower risk for developing osteoporosis, and that excess body fat actually protected against bone loss. However, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) found that having too much internal abdominal fat may, in fact, have a damaging effect on bone health.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment in elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.
› Verified 1 days ago
John Downing, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Miss Faith Nance, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N Ste 202, Nashville, TN 37203 Phone: 615-327-4304 Fax: 615-327-7940 | |
Dr. Holly Ende, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1301 Medical Center Dr, 4648 Tvc, Nashville, TN 37232 Phone: 225-936-9765 | |
Dr. Catherine Jane Coleman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N, Suite 202, Nashville, TN 37203 Phone: 615-327-4304 Fax: 615-327-7940 | |
Katherine Loh, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Alan Hoang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Nicholas Wittig, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N Ste 201, Nashville, TN 37203 Phone: 615-327-4304 Fax: 615-327-7940 |